Electronically facilitated transdermal delivery of human parathyroid hormone (1-34)

International Journal of Pharmaceutics

Volumn 263, Issue 1-2, 2003, Pages 25-33

  Medi, Babu M ^a   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Electroporation; hPTH (1 34); Iontophoresis; Porcine skin; Transdermal drug delivery

Indexed keywords

PARATHYROID HORMONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATOME; DRUG DELIVERY SYSTEM; ELECTRONICS; ELECTROPORATION; IONTOPHORESIS; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SKIN; SKIN ABSORPTION; SKIN PERMEABILITY; STRATUM CORNEUM; SWINE;

EID: 0042884342     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00337-5     Document Type: Article

References (44)

1. Andreason G.L., Evans G.A. Introduction and expression of DNA molecules in eukaryotic cells by electroporation. Biotechniques. 6:1988;650-660.
2. Auer D., Brandner G., Bodemer W. Dielectric breakdown of the red blood cell membrane and uptake of SV 40 DNA and mammalian cell RNA. Naturwissenschaften. 63:1976;391.
3. Behl, C.R., Kumar, S., Malick, A.W., Terzo, S.B., Higuchi, W.I., Srinivasan, V., 1989. Iontophoretic drug delivery: effects of physicochemical factors on the skin uptake of drugs. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York, pp. 603-631.
4. Bhatia K.S., Singh J. Mechanism of transport enhancement of LHRH through porcine epidermis by terpenes and iontophoresis: permeability and lipid extraction studies. Pharm. Res. 15:1998;1857-1862.
5. Bommannan D.B., Tamada J., Leung L., Potts R.O. Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11:1994;1809-1814.
6. Bronaugh, R.L., 1989. Determination of percutaneous absorption by in vitro techniques. In: Brounaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York, pp. 239-258.
7. Bronaugh, R.L., Maibach, H.I. (Eds.), 1989. Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York.
8. Chang S.L., Hofman G.A., Zhang L., Deftos L.J., Banga A.K. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J. Control. Release. 66:2000;127-133.
9. Clowes H.M., Scott R.C., Heylings J.R. Skin absorption: flow through or static diffusion cells. Toxicol. In Vitro. 8:1994;827-830.
10. Dempster D.W., Cosman F., Parisien M., Shen V., Lindsay R. Anabolic actions of parathyroid hormone on bone. Endocr. Rev. 14:1993;690-709.
11. Flynn, G.L., 1989. Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York, pp. 27-51.
12. Gray G.M., Yardley H.J. Lipid composition of cells isolated from pig, human, and rat epidermis. J. Lipid Res. 16:1989;434.
13. Green, P.G., Flanagan, M., Shroot, B., Guy, R.H., 1993. Iontophoretic drug delivery. In: Walters, K.A., Hadgraft, J. (Eds.), Pharmaceutical Skin Penetration Enhancement. Marcel Dekker, New York, pp. 311-333.
14. Guy R.H., Kalia Y.N., Delgado-Charro M.B., Merino V., López A., Marro D. Iontophoresis: electrorepulsion and electroosmosis. J. Control. Release. 64:2000;129-132.
15. Hayton W.L., Chen T. Correction of perfusate concentration for sample removal. J. Pharm. Sci. 71:1982;820-821.
16. Hughes M.F., Shrivastava S.P., Fisher H.L., Hall L.L. Comparative in vitro percutaneous absorption of p-substituted phenols through rat skin using static and flow-through diffusion systems. Toxicol. In Vitro. 7:1993;221-227.
17. Hurst L.N., Brown D.H., Murray K.A. Prolonged life and improved quality for stored skin graft. Plast. Reconstr. Surg. 73:1984;105-109.
18. Kinosita K. Jr., Tsong T.Y. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature. 268:1977;438-441.
19. Martin G.T., Pliquett U.F., Weaver J.C. Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry. 57:2002;55-64.
20. Meyer W., Schwarz R., Neurand K. The skin of domestic mammals as a model for the human skin, with reference to the domestic pig. Curr. Probl. Dermatol. 7:1978;39.
21. Mitlak B.H. Parathyroid hormone as a therapeutic agent. Curr. Opin. Pharmacol. 2:2002;694-699.
22. Mitragotri S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res. 17:2000;1354-1359.
23. Montagna W., Yun J.S. The skin of domestic pig. J. Invest. Dermatol. 43:1964;11.
24. Monteiro-Riviere, N.A., 1986. Ultrastructural evaluation of porcine integument. In: Tumbleson, M.E. (Ed.), Swine in Biomedical Research, Plenum Press, New York, pp. 641-655.
25. Monteiro-Riviere N.A., Inman A.O., Riviere J.E. Identification of the pathway of iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm. Res. 11:1994;251-256.
26. Nabuchi Y., Fujiwara E., Kuboniwa H., Asoh Y., Ushio H. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues. Pharm. Res. 14:1997;1685-1690.
27. Pliquett U. Mechanistic studies of molecular transdermal transport due to skin electroporation. Adv. Drug Deliv. Rev. 35:1999;41-60.
28. Pliquett U.F., Martin G.T., Weaver J.C. Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis. Bioelectrochemistry. 57:2002;65-72.
29. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10504-10508.
30. Prausnitz M.R., Lee C.R., Liu C.H., Pang J.C., Singh T.P., Langer R., Weaver J.C. Transdermal transport efficiency during skin electroporation and iontophoresis. J. Control. Release. 38:1996;205-217.
31. Prausnitz, M.R., Pliquett, U., Vanbever, R., 2000. Mechanistic studies of skin electroporation using biophysical methods. In: Jaroszeski, M.J., Heller, R., Gilbert, R. (Eds.), Electrochemotherapy, Electrogenetherapy and Transdermal Drug Delivery. Humana Press, Totowa, NJ, pp. 213-245.
32. Rastogi S.K., Singh J. Lipid extraction and iontophoretic transport of leuprolide acetate through porcine epidermis. Int. J. Pharm. 215:2001;241-249.
33. Rastogi S.K., Singh J. Transepidermal transport enhancement of insulin by lipid extraction and iontophoresis. Pharm. Res. 19:2002;427-433.
34. Scheuplein, R.J., 1978. Skin as barrier. In: Jarret, A. (Ed.), The Physiology and Pathophysiology of Skin. Academic Press, New York, pp. 1693-1730.
35. Sharma A., Kara M., Smith F.R., Krishnan T.R. Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazocin hydrochloride in hairless rats. J. Pharm. Sci. 89:2000;528-535.
36. Singh J., Bhatia K.S. Topical iontophoretic drug delivery: pathways, principles, factors, and skin irritation. Med. Res. Rev. 16:1996;285-296.
37. Singh S., Singh J. Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med. Res. Rev. 13:1993;569-621.
38. Suzuki Y., Nagase Y., Iga K., Kawase M., Oka M., Yanai S., Matsumoto Y., Nakagawa S., Fukuda T., Adachi H., Higo N., Ogawa Y. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH (1-34). J. Pharm. Sci. 91:2002;350-361.
39. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone. 16:1995;477-484.
40. Walker M., Hulme T.A., Rippon M.G., Walmsley R.S., Gunnigle S., Lewin M., Winsey S. In vitro model(s) for the percutaneous delivery of active tissue repair agents. J. Pharm. Sci. 86:1997;1379-1384.
41. Wang S., Kara M., Krishnan T.R. Transdermal delivery of cyclosporin-A using electroporation. J. Control. Release. 50:1998;61-70.
42. Wester, R.C., Maibach, H.I., 1989. In vivo animal models for percutaneous absorption. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption, Mechanisms-Methodology-Drug Delivery. Marcel Dekker, New York, pp. 221-238.
43. Wester R.C., Melendres J., Sedik L., Maibach H.I., Riviere J.E. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol. Appl. Pharmacol. 151:1998;159-165.
44. Zewert T.E., Pliquett U.F., Langer R., Weaver J.C. Transdermal transport of DNA antisense oligonucleotides by elelctroporation. Biochem. Biophys. Res. Commun. 212:1995;286-292.